pharmaceutical industryScienceThe Yin and Yang of the FDABy Brandon KeimScienceAvandia Skeptic Alleges Intimidation by Company, FDA Issues Strict WarningsBy Brandon KeimScienceGlaxo, Doctors Battle Over Interpretation of New Avandia StudyBy Brandon KeimScienceFDA Drug Safety Worker Was Punished for Pushing Avandia WarningsBy Brandon KeimScienceBig Pharma Picks Ethically Shady Docs to Run Clinical TrialsBy Brandon KeimScienceCongressional Hearings Could Shake Up FDABy Brandon KeimScienceFormer Head of China's FDA Sentenced to DeathBy Brandon KeimSciencePfizer Clinical Trial Foreshadowed 'The Constant Gardener'By Brandon KeimSciencePfizer Faces Criminal Charges in NigeriaBy Brandon KeimScienceFDA Knew About Avandia Risks in 2002By Brandon KeimScienceStates Fight Pharmaceutical Industry Data MiningBy Brandon KeimScienceAvandia Is the New VioxxBy Brandon KeimScienceForget 30 Second Drug Ads -- Why Not a Whole TV Channel?By Brandon KeimScienceShould "Hillbilly Heroin" Makers Go to Jail?By Brandon KeimScienceOff-Label Prescriptions Raise Fears of Pharmaceutical Industry InfluenceBy Brandon KeimScienceA Voice Not Heard at the Biotechnology Industry ConferenceBy Brandon KeimScienceExperimental Drugs, Public Health and a 4-Year-Old Girl With CancerBy Brandon KeimScienceFDA Strengthens Antidepressant Risk LabelsBy Brandon KeimScienceThe Most Promising Drug Target of All: DoctorsBy Brandon KeimScienceMedicare Negotiation Would Save $20 BillionBy Brandon KeimScienceFDA Reforms Go Too Far -- or Not Far EnoughBy Brandon KeimScienceCongress Could Block New Drug AdsBy Brandon KeimScienceThe Sordid History of Cox-2 InhibitorsBy Brandon KeimScienceDrug Critics Dropped From FDA Advisory CommitteeBy Brandon KeimMore Stories